##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 82 Download : 82

##plugins.themes.academic_pro.article.main##

Abstract

Among 80 samples of vaginal swabs taken from female patients at a Maternity Teaching Hospital in Erbil city for the period between May and November 2021 complained of valvovaginitis symptoms, including both intrauterine contraceptive devices (IUCD) and non-intrauterine contraceptive users. The vaginal samples from patients were culture on Sabouraud Dextrose Agar (SDA) and species identification utilizing Chrom agar. The highest incidence rate had discovered in age group of 26-35 years 17(54.84%), followed by >36 years 8(25.81%), and the lowest rates was observed

Keywords

Candida species CHROM agar TLR4 Dectin-1

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Roaa Muhmmed Yahya, Bashar Sadeq Noomi, & Hiba younis Khalaf. (2022). Immunological study of candidiasis in women using intrauterine contraceptive devices in Erbil city. Texas Journal of Medical Science, 13, 155–160. https://doi.org/10.62480/tjms.2022.vol13.pp155-160
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Abdullah Z, Mohammed S. Relationship between Vulvovaginitis in Women with the Candida Species. Kirkuk Journal of Medical Sciences. 2020;8(1):130-41.
  2. Omran EA, Youssef NE, Abdelfattah AH, Esmail SA, Fouad AM. Copper IUD increases virulence of non-albicans Candida species isolated from women with vulvovaginal candidiasis. The European Journal of Contraception & Reproductive Health Care. 2020;25(2):120-5.
  3. Abdullah SMZ. Prevalence of Candida spp. from in women with vulvovaginal infection in Maternity teaching hospital in Erbil, Iraq. Iraq Medical Journal. 2020;4(1).
  4. Mohammed NA, Abdulbaqi NJ, Ajah HA. Epidemiological Study of Candida Species among Vaginal and Oral Candidiasis from different clinical states. International Journal of ChemTech Research. 2017;10(5):844.
  5. Ozcan K, Ilkit M, Ates A, Turac-Bicer A, Demirhindi H. Performance of Chromogenic Candida agar and CHROMagar Candida in recovery and presumptive identification of monofungal and polyfungal vaginal isolates. Medical mycology. 2010;48(1):29-34.
  6. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. Journal of clinical microbiology. 1994;32(8):1923-9.
  7. Abdulla H, Mustafa EAA. Rapid Detection of Candida species Isolated from Denture Stomatitis Patients using Phenotypic methods and Chromogenic agar media. Al-Rafidain Dental Journal. 2020;20(1):125-33.
  8. Swidsinski A, Guschin A, Tang Q, Dörffel Y, Verstraelen H, Tertychnyy A, et al. Vulvovaginal candidiasis: histologic lesions are primarily polymicrobial and invasive and do not contain biofilms. American journal of obstetrics and gynecology. 2019;220(1):91. e1-. e8.
  9. Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, et al. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nature immunology. 2007;8(1):31-8.
  10. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.
  11. Verma AH, Richardson JP, Zhou C, Coleman BM, Moyes DL, Ho J, et al. Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. Science immunology. 2017;2(17):eaam8834.
  12. Pellon A, Sadeghi Nasab SD, Moyes DL. New insights in Candida albicans innate immunity at the mucosa: toxins, epithelium, metabolism, and beyond. Frontiers in Cellular and Infection Microbiology. 2020:81.
  13. Whitney PG, Bär E, Osorio F, Rogers NC, Schraml BU, Deddouche S, et al. Correction: syk signaling in dendritic cells orchestrates innate resistance to systemic fungal infection. PLoS Pathogens. 2018;14(11):e1007366.
  14. McGeachy MJ, Cua DJ, Gaffen SL. The IL-17 family of cytokines in health and disease. Immunity. 2019;50(4):892-906.
  15. Nur S, Sparber F, Lemberg C, Guiducci E, Schweizer TA, Zwicky P, et al. IL-23 supports host defense against systemic Candida albicans infection by ensuring myeloid cell survival. PLoS pathogens. 2019;15(12):e1008115.
  16. Hedayati MT, Taheri Z, Galinimoghadam T, Aghili SR, Cherati JY, Mosayebi E. Isolation of different species of Candida in patients with vulvovaginal candidiasis from Sari, Iran. Jundishapur journal of microbiology. 2015;8(4).
  17. Salvi M. Prevalence of vulvovaginal candidiasis in females in the reproductive age group. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2019;8(2):647-52.
  18. Jasim ST. The relationship between vulvovaginal candidiasis and some predisposing factors in prevalence among Baghdad women. Systematic Reviews in Pharmacy. 2020;11(12):1318-22.
  19. Jacob L, John M, Kalder M, Kostev K. Prevalence of vulvovaginal candidiasis in gynecological practices in Germany: A retrospective study of 954,186 patients. Current medical mycology. 2018;4(1):6.
  20. Salinas AM, Osorio VG, Pacha-Herrera D, Vivanco JS, Trueba AF, Machado A. Vaginal microbiota evaluation and prevalence of key pathogens in ecuadorian women: an epidemiologic analysis. Scientific reports. 2020;10(1):1-18.
  21. Kent HL. Epidemiology of vaginitis. American journal of obstetrics and gynecology. 1991;165(4):1168-76.
  22. Chassot F, Negri MF, Svidzinski AE, Donatti L, Peralta RM, Svidzinski TI, et al. Can intrauterine contraceptive devices be a Candida albicans reservoir? Contraception. 2008;77(5):355-9.
  23. Ghelardi E, Pichierri G, Castagna B, Barnini S, Tavanti A, Campa M. Efficacy of Chromogenic Candida Agar for isolation and presumptive identification of pathogenic yeast species. Clinical microbiology and infection. 2008;14(2):141-7.
  24. Baixench M-T, Taillandier A, Paugam A. Clinical and experimental evaluation of a new chromogenic medium (OCCA®, Oxoid) for direct identification of Candida albicans, C. tropicalis and C. krusei. Mycoses. 2006;49(4):311-5.
  25. Hospenthal DR, Beckius ML, Floyd KL, Horvath LL, Murray CK. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Annals of clinical microbiology and antimicrobials. 2006;5(1):1-5.
  26. Bayona JVM, García CS, Palop NT, Cardona CG. Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples. Diagnostic Microbiology and Infectious Disease. 2020;98(4):115168.
  27. Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, Van Krieken JH, et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. The Journal of Immunology. 2004;172(6):3712-8.
  28. Van der Graaf CA, Netea MG, Morré SA, Den Heijer M, Verweij PE, Van der Meer JW, et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. European cytokine network. 2006;17(1):29-34.
  29. Khan SH, Younus H, Allemailem KS, Almatroudi A, Alrumaihi F, Alruwetei AM, et al. Potential of methylglyoxal-conjugated chitosan nanoparticles in treatment of fluconazole-resistant Candida albicans infection in a murine model. International Journal of Nanomedicine. 2020;15:3681.
  30. Gauglitz GG, Callenberg H, Weindl G, Korting HC. Host defence against Candida albicans and the role of pattern-recognition receptors. Acta Derm Venereol. 2012;92(3):291-8.
  31. Marakalala MJ, Vautier S, Potrykus J, Walker LA, Shepardson KM, Hopke A, et al. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS pathogens. 2013;9(4):e1003315.
  32. Thompson A, Griffiths JS, Walker L, Da Fonseca DM, Lee KK, Taylor PR, et al. Dependence on Dectin-1 varies with multiple Candida species. Frontiers in Microbiology. 2019;10:1800.
  33. Yan W, Zhijian T, Zhixiang L, Dechao X, Jiawen L. Local IL-23 expression in murine vaginal candidiasis and its relationship with infection and immune status. Journal of Huazhong University of Science and Technology [Medical Sciences]. 2006;26(2):245-7.
  34. Li W, Shi W, Yin Y, Chen J, Luo L. Association of IL-17 and IL-23 Gene Variants with Plasma Levels and Risk of Vulvovaginal Candidiasis in a Chinese Han Population. Pharmacogenomics and Personalized Medicine. 2020;13:725.
  35. Monin L, Ushakov D, Arnesen H, Bah N, Jandke A, Munoz-Ruiz M, et al. γδ T cells compose a developmentally regulated intrauterine population and protect against vaginal candidiasis. Mucosal immunology. 2020;13(6):969-81.

Most read articles by the same author(s)